Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 121,300 | 124,700 | 113,600 | 100,100 | 282,200 |
| Depreciation Amortization | 95,100 | 87,200 | 78,800 | 89,000 | 89,900 |
| Income taxes - deferred | 24,300 | 0 | 0 | 0 | 0 |
| Accounts receivable | -8,700 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 19,900 | 0 | 0 | 0 | 0 |
| Other Working Capital | -37,000 | -22,200 | -48,400 | -27,400 | -12,500 |
| Other Operating Activity | -15,700 | -37,400 | -12,300 | 9,100 | -198,800 |
| Operating Cash Flow | $199,200 | $152,300 | $131,700 | $170,800 | $160,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77,400 | -103,800 | -91,400 | -72,500 | -85,800 |
| Net Acquisitions | -69,800 | -47,900 | -248,300 | 13,500 | 0 |
| Other Investing Activity | 6,800 | 4,800 | 2,100 | 18,000 | 0 |
| Investing Cash Flow | $-140,400 | $-146,900 | $-337,600 | $-41,000 | $-85,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10,300 | 0 | 0 | 0 | 0 |
| Debt Issued | 3,000 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 2,300 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | -42,500 | 0 | 0 | 0 | 0 |
| Dividend Paid | N/A | 0 | 0 | 0 | -14,400 |
| Other Financing Activity | 0 | -10,500 | 194,200 | -121,500 | -146,600 |
| Financing Cash Flow | $-47,500 | $-10,500 | $194,200 | $-121,500 | $-161,000 |
| Exchange Rate Effect | -1,000 | 400 | -2,300 | 100 | 300 |
| Beginning Cash Position | 1,700 | 6,400 | 20,400 | 12,000 | 97,700 |
| End Cash Position | 12,000 | 1,700 | 6,400 | 20,400 | 12,000 |
| Net Cash Flow | $10,300 | $-4,700 | $-14,000 | $8,400 | $-85,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 199,200 | 152,300 | 131,700 | 170,800 | 160,800 |
| Capital Expenditure | -77,400 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 121,800 | 152,300 | 131,700 | 170,800 | 160,800 |